AION Labs, In Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations
Similar Posts
eVisit Closes $45 Million in Series B Funding Round Led by Goldman Sachs Asset Management
eVisit, the leading Virtual Care platform for large healthcare providers, today announced that it has closed a $45 million…
Availity Earns 2021 Great Place to Work Certification
Health information network receives workplace award Availity, one of the nation’s largest real-time health information networks, is proud to…
RCare Partners with Nxtgen Care to Improve ‘Meaningful Life’ and COVID Protections for Liberty Senior Living
RCare, Inc. (Response Care), creator of advanced nurse call and monitoring solutions, and Nxtgen Care, creator of a…
Phillips-Medisize Expands Clinical Manufacturing Capabilities to Serve Drug Delivery Device Market
Phillips-Medisize, a Molex company, announced expansion of its current Global Innovation and Development (GID) site in Struer, Denmark with a dedicated Manufacturing Development and…
Leon Medical Centers Partners with Health Tech Company Rimidi, Reducing A1Cs in High-Risk Cohort of Patients with Type 2 Diabetes
84% of patients being remotely monitored by Leon clinicians using Rimidi’s platform have improved their A1C to below 9%…